# Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea

> **NCT05303935** · PHASE2 · COMPLETED · sponsor: **Flinders University** · enrollment: 15 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Quetiapine 50 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05303935
- **Lead sponsor:** Flinders University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-25
- **Primary completion:** 2023-04-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303935, "Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05303935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*